7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Malocclusion D008310 3 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Periodontal Diseases D010510 15 associated lipids
Osteitis Deformans D010001 3 associated lipids
Dental Pulp Necrosis D003790 6 associated lipids
Crohn Disease D003424 12 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Fractures, Stress D015775 2 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
Thyroid Diseases D013959 8 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Myocardial Ischemia D017202 11 associated lipids
Paraneoplastic Syndromes D010257 4 associated lipids
Sepsis D018805 11 associated lipids
Periodontal Pocket D010514 9 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Shah AP et al. Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. 2016 PLoS ONE pmid:27019421
Dela Cruz A et al. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:27006198
Lis GJ et al. Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. 2016 Pol. Arch. Med. Wewn. pmid:27003233
Yuan SY et al. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. 2016 Chin J Nat Med pmid:27114313
Davaine JM et al. Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. 2016 Eur J Vasc Endovasc Surg pmid:26652270
Li J et al. Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro. 2016 Mol Med Rep pmid:26647856
Cervellati C et al. Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia. 2016 Oxid Med Cell Longev pmid:26635910
Li M et al. Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis. 2016 J. Biol. Chem. pmid:27697839
Shirakawa J and Kulkarni RN Novel factors modulating human β-cell proliferation. 2016 Diabetes Obes Metab pmid:27615134
Xing R et al. Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. 2016 Int. J. Mol. Med. pmid:27599586

Table of Content